---
title: "Medicus Pharma Highlights Strong Phase 2 SkinJect Results in Basal Cell Carcinoma"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278399207.md"
description: "Medicus Pharma Highlights Strong Phase 2 SkinJect Results in Basal Cell Carcinoma"
datetime: "2026-03-09T13:19:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278399207.md)
  - [en](https://longbridge.com/en/news/278399207.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278399207.md)
generator: "portal-rs"
---

# Medicus Pharma Highlights Strong Phase 2 SkinJect Results in Basal Cell Carcinoma

Medicus Pharma Highlights Strong Phase 2 SkinJect Results in Basal Cell Carcinoma

### Related Stocks

- [MDCXW.US](https://longbridge.com/en/quote/MDCXW.US.md)
- [MDCX.US](https://longbridge.com/en/quote/MDCX.US.md)

## Related News & Research

- [Medicus Surges on New Data](https://longbridge.com/en/news/298337158.md)
- [Medicus Pharma pivots to precision oncology, prioritizing CD228V melanoma proof-of-concept study](https://longbridge.com/en/news/298310825.md)
- [Medicus Pharma signs co-development, licensing deal with Pfizer for CD228V antibody-drug conjugate](https://longbridge.com/en/news/297910433.md)
- [Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update | MDCX Stock News](https://longbridge.com/en/news/295715209.md)
- [EXCLUSIVE: Medicus Pharma Launches Genomics-Guided Endometriosis Study In Abu Dhabi](https://longbridge.com/en/news/294506242.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**